These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6524800)

  • 1. [Psychotic manifestations in myasthenia gravis].
    Schmitt L; Arrue P; Escande M; Rascol A; Gayral L
    Ann Med Psychol (Paris); 1984; 142(7):1007-11. PubMed ID: 6524800
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful desensitization protocol for pyridostigmine hypersensitivity in a patient with myasthenia gravis.
    Aung T; Dowden AY
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):308. PubMed ID: 23535103
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.
    Gehi A; Benatar M; Langberg J
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):214-6. PubMed ID: 17711430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cause of reversible dysphagia: an unusual presentation of myasthenia gravis.
    Brostoff JM; Dahdaleh D; Birns J
    Eur J Intern Med; 2008 Jan; 19(1):70. PubMed ID: 18206608
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case report of pyridostigmine induced parkinsonism].
    Iwasaki Y; Kinoshita M; Wakata N
    Rinsho Shinkeigaku; 1988 Jun; 28(6):662-4. PubMed ID: 3233838
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrence of non-myasthenic symptoms with myasthenia gravis.
    Iseki K; Mezaki T; Kawamoto Y; Tomimoto H; Fukuyama H; Shibasaki H
    Neurol Sci; 2007 Apr; 28(2):114-5. PubMed ID: 17464478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma.
    Gajra A; Vajpayee N; Grethlein SJ
    Am J Hematol; 2004 Oct; 77(2):196-7. PubMed ID: 15389902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic alopecia caused by pyridostigmine bromide.
    Field LM
    Arch Dermatol; 1980 Oct; 116(10):1103. PubMed ID: 7425657
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis.
    Comerci G; Buffon A; Biondi-Zoccai GG; Ramazzotti V; Romagnoli E; Savino M; Rebuzzi AG; Biasucci LM; Loperfido F; Crea F
    Int J Cardiol; 2005 Sep; 103(3):335-7. PubMed ID: 16098399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When the patient fails to respond to treatment: myasthenia gravis.
    Hilton-Jones D
    Pract Neurol; 2007 Nov; 7(6):405-11. PubMed ID: 18024782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myasthenia gravis and non-Hodgkin's lymphoma].
    Campello Morer I; Marta Moreno E; Capablo Liesa JL; Alvarez Alegret R; Giraldo Castellanos P
    Neurologia; 1995; 10(6):246-8. PubMed ID: 7546817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
    Bau V; Hanisch F; Hain B; Zierz S
    Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spurious hyperchloremia and hyperbicarbonatemia in a patient receiving pyridostigmine bromide therapy for myasthenia gravis.
    Wacks I; Oster JR; Pérez GO; Kett DH
    Am J Kidney Dis; 1990 Jul; 16(1):76-9. PubMed ID: 2368710
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis and scleroderma.
    Bhalla R; Swedler WI; Lazarevic MB; Ajmani HS; Skosey JL
    J Rheumatol; 1993 Aug; 20(8):1409-10. PubMed ID: 8230029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced neonatal myasthenia.
    Buckley GA; Roberts DV; Roberts JB; Thomas BH; Wilson A
    Br J Pharmacol; 1968 Sep; 34(1):203P-204P. PubMed ID: 5692081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Asystole during electroconvulsive therapy in a patient with depression and myasthenia gravis].
    Otsuka H; Shikama H; Saito T; Ishikawa T; Kemmotsu O
    Masui; 2000 Aug; 49(8):893-5. PubMed ID: 10998885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFFECT OF EMOTIONS ON USE OF MEDICATION IN MYASTHENIA GRAVIS.
    CLAMAN L; JOHNSTONE RE
    Tex State J Med; 1965 Jan; 61():49-51. PubMed ID: 14226987
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyridostigmine-induced microcephaly.
    Al-Shekhlee A; Robin N; Kaminski HJ
    Neurology; 2001 Jun; 56(11):1606-7. PubMed ID: 11402134
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyridostigmine-induced microcephaly.
    Polizzi A; Ruggieri M; Vincent A
    Neurology; 2001 Jun; 56(11):1606-7. PubMed ID: 11409415
    [No Abstract]   [Full Text] [Related]  

  • 20. Laryngeal myasthenia gravis: report of 40 cases.
    Mao VH; Abaza M; Spiegel JR; Mandel S; Hawkshaw M; Heuer RJ; Sataloff RT
    J Voice; 2001 Mar; 15(1):122-30. PubMed ID: 12269627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.